Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   The mechanism of Raf activation through dimerization
  2. Zhang,Mingzhen; Maloney,Ryan; Jang,Hyunbum; Nussinov,Ruth
  3. Chemical Science. 2021, Dec 08; 12(47): 15609-15619.
  1. 2.   Arginine Methylation by PRMT5 at a Naturally Occurring Mutation Site Is Critical for Liver Metabolic Regulation by Small Heterodimer Partner
  2. Kanamaluru, D.; Xiao, Z.; Fang, S. S.; Choi, S. E.; Kim, D. H.; Veenstra, T. D.; Kemper, J. K.
  3. Molecular and Cellular Biology. 2011, Apr; 31(7): 1540-1550.
  1. 3.   Signaling dynamics of the KSR1 scaffold complex
  2. McKay, M. M.; Ritt, D. A.; Morrison, D. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009, Jul 7; 106(27): 11022-7.
  1. 4.   Limb Development Takes a Measured Step Toward Systems Analysis
  2. Mackem, S.; Lewandoski, M.
  3. Science Signaling. 2009, May; 2(71): 4.
  1. 5.   Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation
  2. Miao, J.; Xiao, Z.; Kanamaluru, D.; Min, G.; Yau, P. M.; Veenstra, T. D.; Ellis, E.; Strom, S.; Suino-Powell, K.; Xu, H. E.; Kemper, J. K.
  3. Genes & Development. 2009 23(8): 986-996.
  1. 6.   LIM homeobox transcription factors integrate signaling events that control three-dimensional limb patterning and growth
  2. Tzchori, I.; Day, T. F.; Carolan, P. J.; Zhao, Y.; Wassif, C. A.; Li, L.; Lewandoski, M.; Gorivodsky, M.; Love, P. E.; Porter, F. D.; Westphal, H.; Yang, Y.
  3. Development. 2009 136(8): 1375-1385.
  1. 7.   Differential control of the CCAAT/enhancer-binding protein beta (C/EBP beta) products liver-enriched transcriptional activating protein (LAP) and liver- enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during th
  2. Li, Y.; Bevilacqua, E.; Chiribau, C. B.; Majumder, M.; Wang, C. P.; Croniger, C. M.; Snider, M. D.; Johnson, P. F.; Hatzoglou, M.
  3. Journal of Biological Chemistry. 2008 283(33): 22443-22456.
  1. 8.   Experimental validation for quantitative protein network models
  2. Nishizuka, S.; Spurrier, B.
  3. Current Opinion in Biotechnology. 2008 19(1): 41-49.
  1. 9.   FGFR1 function at the earliest stages of mouse limb development plays an indispensable role in subsequent autopod morphogenesis
  2. Li, C. L.; Xu, X. L.; Nelson, D. K.; Williams, T.; Kuehn, M. R.; Deng, C. X.
  3. Development. 2005, NOV; 132(21): 4755-4764.
  1. 10.   Gadd45a acts as a modifier locus for lymphoblastic lymphoma
  2. Hollander, M. C.; Patterson, A. D.; Salvador, J. M.; Anver, M. R.; Hunger, S. P.; Fornace, A. J.
  3. Leukemia. 2005, MAY; 19(5): 847-850.
  1. 11.   Substrate specificity of the human protein phosphatase 2C delta Wip1
  2. Yamaguchi, H.; Minopoli, G.; Demidov, O. N.; Chatterjee, D. K.; Anderson, C. W.; Durell, S. R.; Appella, E.
  3. Biochemistry. 2005, APR 12; 44(14): 5285-5294.
  1. 12.   Quantitative kinetic analysis of the bacteriophage lambda genetic network
  2. Kobiler, O.; Rokney, A.; Friedman, N.; Court, D. L.; Stavans, J.; Oppenheim, A. B.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005 102(12): 4470-4475.
  1. 13.   Caspase-mediated apoptosis and caspase-independent cell death induced by irofulven in prostate cancer cells
  2. Liang, H. Y.; Salinas, R. A.; Leal, B. Z.; Kosakowska-Cholody, T.; Michejda, C. J.; Waters, S. J.; Herman, T. S.; Woynarowski, J. M.; Woynarowska, B. A.
  3. Molecular Cancer Therapeutics. 2004, NOV; 3(11): 1385-1396.
  1. 14.   Simultaneous topography and recognition Imaging using force microscopy
  2. Stroh, C. M.; Ebner, A.; Geretschlager, M.; Freudenthaler, G.; Kienberger, F.; Kamruzzahan, A. S. M.; Smith-Gil, S. J.; Gruber, H. J.; Hinterdorfer, P.
  3. Biophysical Journal. 2004, SEP; 87(3): 1981-1990.
  1. 15.   Regulation of HDM2 activity by the ribosomal protein L11
  2. Lohrum, M. A. E.; Ludwig, R. L.; Kubbutat, M. H. G.; Hanlon, M.; Vousden, K. H.
  3. Cancer Cell. 2003 3(6): 577-587.
  1. 16.   Activation and activities of the p53 tumour suppressor protein
  2. Balint, E.; Vousden, K. H.
  3. British Journal of Cancer. 2001 85(12): 1813-1823.
  1. 17.   Stress signals utilize multiple pathways to stabilize p53
  2. Ashcroft, M.; Taya, Y.; Vousden, K. H.
  3. Molecular and Cellular Biology. 2000 20(9): 3224-3233.
  1. 18.   Regulation and activation of p53 and its family members
  2. Lohrum, M. A. E.; Vousden, K. H.
  3. Cell Death and Differentiation. 1999 6(12): 1162-1168.
  1. 19.   Regulation of p53 stability
  2. Ashcroft, M.; Vousden, K. H.
  3. Oncogene. 1999 18(53): 7637-7643.
  1. 20.   Distribution and Localization of a Novel Cholecystokinin-Releasing Factor in the Rat Gastrointestinal Tract
  2. Tarasova, N.; Spannagel, A. W.; Green, G. M.; Gomez, G.; Reed, J. T.; Thompson, J. C.; Hellmich, M. R.; Reeve, J. R.; Liddle, R. A.; Greeley, G. H.
  3. Endocrinology. 1997 138(12): 5550-5554.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel